[#item_full_content] The Drug Enforcement Administration (DEA) is scheduled to hold a hearing later this month to consider the broader federal rescheduling of cannabis. The move follows U.S. Attorney General Todd Blanche’s order from April to immediately reclassify state-licensed medical marijuana from Schedule I to Schedule III. Although some observers have said that the direct effects of rescheduling  Read More